Current concepts in the therapeutic management of osteoarthritis with glucosamine

Bulletin: Hospital for Joint Diseases

Volumn 63, Issue 1-2, 2005, Pages 31-36

  Reginster, Jean Yves ^a,b,c   Bruyere, Olivier ^a,b   Fraikin, Genevieve ^a   Henrotin, Yves ^b  

^a WHO Collaborating Center for Public Health Aspects of Rheumatic Diseases   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c Policliniques L BRULL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM CARBONATE; CHONDROITIN SULFATE; GLUCOSAMINE SULFATE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO;

ARTICLE; CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DRUG FORMULATION; EPIGASTRIC PAIN; GASTROINTESTINAL TOXICITY; HEARTBURN; HUMAN; JOINT CAVITY; KNEE OSTEOARTHRITIS; LEG; OSTEOARTHRITIS; RELIABILITY; SPINE;

DRUGS, NON-PRESCRIPTION; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PRESCRIPTIONS, DRUG; TREATMENT OUTCOME;

EID: 24144436942     PISSN: 00185647     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Setnikar I, Cereda R, Pacine MA, et al: Antireactive properties of glucosamine sulfate. Arzneim-Forsch/Drug Res 1991;41:157-61.
2. 4) on human chondrocyte gene expression. Osteoarthritis Cartilage 1997;5(SA):72.
3. Dodge GR, Hawkins JF, Jimenez SA: Modulation of aggrecan, MMP1 and MMP3 productions by glucosamine sulfate in cultured human osteoarthritis articular chondrocytes. Arthritis Rheum 1999;42S:253.
4. Basleer C, Rovati L, Franchimont P: Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritis articular cartilage in vitro. Osteoarthritis Cartilage 1998;6:427-34.
5. Sandy JD, Gamett D, Thompson V, et al: Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J 1998;355:59-66.
6. Abelda SM, Buck CA: Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-80.
7. Piperno M, Reboul P, Hellio Le Graverand MP, et al: Glucosamine sulfate modulates dysregulated activities of human osteoarthritis chondrocytes in vitro. Osteoarthritis Cartilage 2000;8:207-12.
8. Conrozier T, Mathieu P, Piperno M: Glucosamine sulfate significantly reduced cartilage destruction in a rabbit model of osteoarthritis. Arthritis Rheum 1998;41S:147.
9. Reichelt A, Förster KK, Fischer M, et al: Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. Arzneim-Forsch/Drug Res 1994;44:75-80.
10. Setnikar I, Palumbo R, Canali S, et al: Pharmacokinetics of glucosamine in man. Arzneim-Forsch/Drug Res 1993;43:1109-13.
11. Noack W, Fischer M, Förster KK, et al: Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994;2:51-9.
12. Leffler CT, Philippi AF, Leffler SG, et al: Glucosamine, chodroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: A randomized, double-blind, placebo-controlled pilot study. Military Medicine 1999;164:85-91.
13. Rovati LC: Clinical development of glucosamine sulfate as selective drug in osteoarthritis. Rheumatology in Europe 1997;26:70.
14. Houpt JB, McMillan R, Wein C, et al: Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999;26:2423-30.
15. Rovati LC: Clinical efficacy of glucosamine sulfate in osteoarthritis of the spine. Rev Esp Reumatol 1993;20(S1):325.
16. Muller-Fassbender H, Bach GL, Haase W, et al: Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994;2:61-9.
17. Qiu GX, Gao SN, Giacovelli G, et al: Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneim-Forsch/Drug Res 1998;48:469-74.
18. Rovati LC: The clinical profile of glucosamine sulfate as a selective symptom modifying drug in osteoarthritis: Current data and perspectives. Osteoarthritis Cartilage 1997;5(SA):72.
19. Thie NMR, Prasad NG, Major PW: Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporo-mandibular joint osteoarthritis: A randomized double blind controlled 3 month clinical trial. J Rheum 2001;28:1347-55.
20. Cohen M, Wolfe R, Mai T, et al: A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheum 2003;30:523-8.
21. Hughes R, Carr A: A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology 2002;41:279-84.
22. Rindone JP, Hiller D, Collacott E, et al: Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med 2000;172:91-4.
23. McAlindon T: Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin N Am 2003;29:789-801.
24. Zeisel SH: Regulation of "neutraceuticals." Science 1999;285:1853-5.
25. McAlindon T, Formica M, LaValley M, et al: Effectiveness of glucosamine for symptoms of knee osteoarthritis: Results from an Internet-based randomized double-blind controlled trial. Am J Med 2004;117:643-9.
26. Leeb BF, Schweitzer H, Montag K, et al: A meta-analysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000;27:205-11.
27. McAlindon TE, LaValley MP, Felson DT: Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.
28. Richy F, Bruyere O, Ethgen O, et al: Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. Arch Intern Med 2003;163:1514-22.
29. Towheed TE, Anastassiades TP: Glucosamine therapy for osteoarthritis. J Rheumatol 1999;26:2294-7.
30. Reginster JY, Deroisy R, Rovati LC: Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
31. Pavelka K, Gatterova J, Olejarova M, et al: Glucosamine sulfate use and delay of progression of knee osteoarthritis. Arch Int Med 2002;162:2113-23.
32. Bruyère O, Honore A, Rovati LC, et al: Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scand J Rheumatol 2002;31:13-6.
33. Bruyère O, Honore A, Etghen O, et al: Correlation between radiographic severity of knee osteoarthritis and future disease progression: Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 2003;11:1-5.
34. Christgau S, Henrotin Y, Tanko LB, et al: Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin Exp Rheum 2004;22:36-42.
35. Mazzuca SA, Brandt KD, Lane KA, et al: Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees. Arthritis Rheum 2002;46:1223-7.
36. Pavelka K, Bruyère O, Rovati LC, et al: Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials. Osteoarthritis Cartilage 2003;11:730-7.
37. Altman RD, Abadie E, Avouac B, et al: Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage (In press).
38. Tapadinhas MJ, Rivera IC, Bignamini AA: Oral glucosamine sulphate in the management of arthrosis: Report on a multicentre open investigation in Portugal. Pharmacotherapeutica 1982;3:157-68.
39. Adams ME: Hype about glucosamine. Lancet 1999;354:353-4.
40. Rovati LC, Annefeld M, Giacovelli G, et al: Glucosamine in osteoarthritis. Lancet 1999;354:1640.
41. Russell AS, Aghazadeh-Habashi A, Jamali F: Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 2002;29:2407-9.
42. AbdelFattah W, Hammad T: Chondroitin sulfate and glucosamine: A review to their safety profile. JAMA 2001;3:17-24.
43. Matheson AJ, Perry CM: Glucosamine: A review of its use in the management of osteoarthritis. Drugs Aging 2003;20:1041-60.
44. Tannis AJ, Barban J, Conquer JA: Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals. Osteoarthritis Cartilage 2004;12:506-11.